Evidence map›Paper›PMID 33005010›Full record

ArticleCommunications biology2020

FUBP1 and FUBP2 enforce distinct epigenetic setpoints for MYC expression in primary single murine cells.

Ying Zheng, Wendy Dubois, Craig Benham, Eric Batchelor, David Levens

Abstract read
In one paragraph

Article in Communications biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Dynamic Supercoiling Sponsors Transcription Amplification by MYC.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. MYC: a complex problem.Trends in cell biology · 2023
    Review
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ying ZhengLab of Pathology, National Cancer Institutes, Bethesda, MD, USA.
Wendy DuboisLab of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institutes, Bethesda, MD, USA.
Craig BenhamBiomedical Engineering, University of California, Davis, CA, USA.
Eric BatchelorMasonic Cancer Center and Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, MN, USA.
David LevensLab of Pathology, National Cancer Institutes, Bethesda, MD, USA. levensd@mail.nih.gov.

Funding

Mechanisms of transcription factor integration at the c-myc promoterZIASC009144 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI LEVENS, DAVID L. · 2009 to 2025
$9.5M
c-Myc FunctionZIABC011465 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEVENS, DAVID L. · 2012 to 2025
$8.6M
Intramural NIH HHS ZIA BC011465Intramural NIH HHS ZIA SC009144NCI NIH HHS ZIA BC 011465NCI NIH HHS ZIA SC 009144
6 · The paper itself

Abstract

Physiologically, MYC levels must be precisely set to faithfully amplify the transcriptome, but in cancer MYC is quantitatively misregulated. Here, we study the variation of MYC amongst single primary cells (B-cells and murine embryonic fibroblasts, MEFs) for the repercussions of variable cellular MYC-levels and setpoints. Because FUBPs have been proposed to be molecular "cruise controls" that constrain MYC expression, their role in determining basal or activated MYC-levels was also examined. Growing cells remember low and high-MYC setpoints through multiple cell divisions and are limited by the same expression ceiling even after modest MYC-activation. High MYC MEFs are enriched for mRNAs regulating inflammation and immunity. After strong stimulation, many cells break through the ceiling and intensify MYC expression. Lacking FUBPs, unstimulated MEFs express levels otherwise attained only with stimulation and sponsor MYC chromatin changes, revealed by chromatin marks. Thus, the FUBPs enforce epigenetic setpoints that restrict MYC expression.

Indexed as

Epigenesis, GeneticAnimalsB-LymphocytesChromatinDNA-Binding ProteinsFibroblastsGene Expression RegulationMiceProto-Oncogene Proteins c-mycRNA-Binding ProteinsRNA, MessengerChromatinDNA-Binding Proteinsfubp1 protein, mouseMyc protein, mouseProto-Oncogene Proteins c-mycRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID33005010
PMCPMC7530719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.